|
|
||||||||
Department of Medicine, Physiology and Biophysics, University of Calgary, Calgary, Alberta, Canada; and Center of Molecular Therapeutics, Department of Pharmacology, Columbia University, New York, New York
ABSTRACT I. INTRODUCTION A. Overview of Ca2+ Transport in the Cardiac Cell 1. Structural aspects 2. Model of ECC 3. ECC coupling in atrial and Purkinje cells from normal hearts 4. Reversal of ECC II. MOLECULAR BUILDING BLOCKS OF EXCITATION-CONTRACTION COUPLING A. Ca2+ Flux Through the Sarcolemma 1. Ca2+ entry through voltage-gated channels 2. Na+/Ca2+ exchange, Ca2+ entry, and Ca2+ efflux 3. Stretch-sensitive Ca2+ flux B. Intracellular Ca2+ Cycling 1. SR Ca2+-ATPase pump 2. Ryanodine-sensitive SR-Ca2+ release channels (RyR) A) POTASSIUM AND CHLORIDE CHANNELS IN THE SR MEMBRANE. B) RYANODINE RECEPTORS AND CALCIUM OVERLOAD OF THE SR. 3. IP3-dependent Ca2+ release 4. Mitochondria Ca2+ transport C. Intracellular Ligands and Buffers 1. Sarcolemmal Ca2+ binding 2. Intracellular ligands III. FUNCTIONAL CONSEQUENCES OF CALCIUM CYCLING A. Macroscopic Events 1. The cardiac cycle: cytosolic Ca2+ transients and force development B. Microscopic Events 1. Ca2+ sparks in normal cardiac ventricular muscle A) CALCIUM SPARKS IN ATRIAL AND PURKINJE CELLS. 2. Microscopic Ca2+ waves in normal muscle 3. Ca2+ waves in intact whole hearts C. Regulation of Ca2+ Transport IV. CALCIUM AND ARRHYTHMOGENESIS A. Inherited Mutations That Cause Ca2+-Dependent Arrhythmias 1. RyR2 mutations and arrhythmias A) FUNCTIONAL IMPLICATIONS. 2. CASQ mutations and arrhythmias A) FUNCTIONAL IMPLICATIONS. 3. Ca2+ channel mutations and arrhythmias 4. Ankyrin B mutations and arrhythmias 5. Long QT syndromes and Ca2+-dependent arrhythmias B. Automaticity 1. Normal automaticity A) SAN CELLS. B) ATRIAL PACEMAKER CELLS. C) AV NODAL CELLS. D) NORMAL PURKINJE FIBERS. 2. Abnormal automaticity 3. Triggered activity A) ROLE OF CALCIUM IN EADS. B) ARRHYTHMIAS, DADS, AND CALCIUM WAVES IN MYOCARDIUM. C. Re-entrant Excitation 1. Ca2+ and impulse propagation 2. Ca2+ and gap junction permeability D. Nonuniform ECC and Electromechanical Alternans V. SUMMARY GRANTS ACKNOWLEDGMENTS REFERENCES
| ABSTRACT |
|---|
|
|
|---|
| I. INTRODUCTION |
|---|
|
|
|---|
A. Overview of Ca2+ Transport in the Cardiac Cell
The cell border is delineated by a glycoprotein layer overlying the sarcolemma, which invaginates the cell near the Z lines of the myofibrils. The resultant transverse tubules (t tubules) are rich in dihydropyridine-sensitive Ca2+ channels (DHPR) and Na+/Ca2+ exchange proteins. The t tubules make contact with a longitudinal network of tubules with lipid membranes called the sarcoplasmic reticulum (SR), which is a prominent Ca2+ storage organelle. Terminal cisternae of the SR abutting the t tubules contain Ca2+ channels with a high affinity for ryanodine (RyRs) that are involved in Ca2+ release from the SR. The RyR are so large that they form ultrastructurally recognizable junctional "foot proteins" in close proximity to the DHPR (Fig. 1). The longitudinal SR envelops the myofibrils and is densely covered by SERCA, SR Ca2+ pump molecules, which drive Ca2+ into the SR where it is buffered in the longitudinal SR by calreticulin and in the junctional SR by calsequestrin, a protein with intermediate affinity for Ca2+. The pump rate of SERCA depends on the [Ca2+]i. The Ca2+ sensitivity of the pump is controlled by the degree of phosphorylation of the regulatory protein, phospholamban, in the SR membrane. The contractile proteins arranged in sarcomeres in the myofibrils occupy 60% of the intracellular space. Mitochondria adjacent to the sarcomeres occupy the remainder of the cell.
|
The action potential initiates the release of Ca2+ by mechanisms that are specialized in different cardiac tissues. The most well known specialization of the release units is found in ventricular myocytes, which is penetrated in a highly organized manner by transverse tubules of the cell membrane. The t tubules in these cells make contact with the terminal cisternae of the SR (70, 162, 518). The latter specialized junctional domains of the SR, containing calsequestrin (CASQ) and carrying protein "feet" on their cytoplasmic surface, contact t tubules in the form of dyads. Similar domains of the SR not associated with the cell membrane form so-called corbular SR. The molecular composition of the dyad is now beginning to be revealed. A linking protein junctophyllin is thought to be involved in the docking of t tubules on the dyads (518). While a majority of DHPR and RyR are colocalized in dyads (478), the observation that a significant fraction of RyR is not colocalized with DHPR (40% in adult rat myocytes) suggests that these RyR could be present in the corbular SR. On the luminal side of the junctional domains, the intra SR proteins, CASQ and junctin and triadin, are colocalized with RyR. Studies of the macromolecular protein assemblies have suggested that complete assembly of RyR/DHPR on the one side of the dyad and RyR/TrD (triadin)/JnC (junctin)/CASQ on the luminal side develops during maturation of the animal allowing efficient coupling between surface membrane depolarization and Ca2+ delivery to the myofibrils throughout an adult cardiac myocyte.
The ultrastructure of Purkinje and atrial cells differs from the above structure described for ventricular myocytes in that they have no t tubules and their SR presents in two forms, subsarcolemmal junctional SR and corbular SR located in the core of the cell (505) (Fig. 1). The diameter of a Purkinje cell is 3040 µm. The diameter of a normal ventricular myocyte is 1525 µm, whereas an atrial cell is 1315 µm. Furthermore, the density of the myofibrils is lower in the Purkinje cell compared with that in ventricular myocytes. Accordingly, it has been shown that for both the small atrial myocyte and the large Purkinje cell, ECC relies on a process where surface membrane depolarization and Ca2+ delivery to myofibrils deep inside the myocyte depend on Ca2+ release by the SR, which starts at the cell membrane and which is propagated by chemical transmission to the depth of the cell (513).
A descriptive model of ECC (Fig. 2) has been developed to explain the functional properties of the cardiac cell (476). During the action potential Ca2+ enter the cell through a protein that is sensitive to dihydropyridine, a DHPR or "L-type Ca2+" channels. In ventricular cells the number of Ca2+ channels is estimated to be 15/µm2 and yet only 3% are open at peak currents (317). The amount of Ca2+ entering the cell per second depends on action potential duration and heart rate. Ca2+ influx at t tubules is 2.3x that of the cell surface, but more Ca2+ entry occurs per square micron at the cell surface than at t tubules (69). Ca2+ entering via L-type Ca2+ channels in the t tubules start ECC by triggering release of Ca2+ from the RyR in the terminal cisternae. In the rat (48), the ratio of RyR to L-type Ca2+ channels is 7:1 and would fit spatially with random coupling of the L-type Ca2+ channel to Ca2+ release via RyR (79). The ratio of superficial L-type Ca2+ channels versus t-tubular L-type channels is 1:3 (586), and it is anticipated then that one t-tubular L-type channel faces
10 RyRs. Ca2+-induced Ca2+ release (CICR) is proportional to the free intra-SR Ca2+ content and dictates the force of the cardiac contraction. Free Ca2+ in the SR has recently been spatially resolved (484), and data show that intra-SR Ca2+ diffusion is rapid, and local Ca2+ in SR in normal ventricular cells is never less than 50% of the diastolic value. The released Ca2+ activates contraction of the sarcomere. This contraction is short lived due to the rapid elimination of Ca2+ from the cytosol (Fig. 3A). About two-thirds of the Ca2+ is resequestered by the SR (45); the remainder leaves the cell mostly via the low-affinity, high-capacity, Na+/Ca2+ exchanger, while a low-capacity, high-affinity Ca2+ pump lowers the cytosolic Ca2+ level further during the diastolic interval (84). In the steady-state, the sum of the Ca2+ efflux through the membrane balances the influx during the action potential. It follows, then, that the Ca2+ content of the SR depends on the heart rate and on the duration of the action potential. Furthermore, a fraction of the Ca2+ involved in activation of the heartbeat recirculates into the SR and becomes available for activation of the next beat. Thus force of the heartbeat will depend on the force of the previous one. In addition, it takes time for the Ca2+ release process to recover completely from the last release so that sequestered Ca2+ can again be released from the SR. Therefore, the force of the heartbeat will also depend strongly on heart rate, on the duration of the diastolic interval, as well as on the duration of the action potential (594).
|
|
3. ECC coupling in atrial and Purkinje cells from normal hearts
In rabbit atrial cells, immunostaining for either RyR or the L-type Ca2+ channel can be seen near the cell's sarcolemma (84a). Nonjunctional SR elements visualized with RyR staining are in transverse arrays along the Z lines (284, 610). In rat atrial cells, a 0.5- to 1-µm gap exists between junctional and nonjunctional RyR (341). This is in contrast to the unique ultrastructure of the latent atrial pacemaker cell, where subsarcolemmal SR cisternae are prominent and directly opposed to one another in adjacent cells. Differing from normal ventricular cell ultrastructure, where the presence of t tubules ensures reasonably synchronous Ca2+ release throughout the cell, atrial cells exhibit spatial Ca2+ gradients. In response to electrical stimulation, Ca2+ increases first at the cell's periphery and then after a 30- to 50-ms delay, increases in the central regions of the cell (38, 232, 284, 329, 341, 596). Preferential activation of Ca2+ sparks along the cell's periphery and then propagation to the cell's core (487, 596) is consistent with the biphasic nature of the human atrial Ca2+ transient under voltage clamp (198) and the ability of peripheral Ca2+ release to more efficiently regulate Na+/Ca2+ exchanger function (328). Furthermore, in rat atrial cells, a set of "eager" Ca2+ release sites that have a fixed edge location and preset activation pattern are thought to reflect clusters of RyRs that are closely coupled to Ca2+ channels and display a high sensitivity to trigger Ca2+ (341). In voltage-clamped cAMP-stimulated atrial cells, L-type Ca2+ channel evoked peripheral Ca2+ release occurs within 14 ms, and this Ca2+ then propagates to the interior of the cell at
230 µm/s (596). The efficacy of Ca2+ currents to trigger peripheral Ca2+ release is fivefold greater than that needed for triggering center Ca2+ release. Thus, for rat cells, it is thought that the mechanism of Ca2+ release from junctional SR differs from that in nonjunctional SR. Recent spark data suggest that peripheral atrial Ca2+ sparks are brighter and occur more frequently than central sparks (597). The opposite appears to be the case in feline atrial cells (284) where under permeabilized conditions, Ca2+ spark frequencies in the two regions are similar (488). Thus, in the intact cell, mechanisms that cause Ca2+ release in central SR RyRs are not efficient, most probably because of structural components. An interesting report by MacKenzie et al. (343) states that inherent intracellular calcium buffers in the normal rat atrial cell (for instance, mitochondria and SERCA pumps) prevent global Ca2+ transients under normal-paced conditions. Furthermore, membrane depolarization evoked peripheral Ca2+ release only propagates to the cell's core when the cell is hormonally (e.g., endothelin) stimulated.
As a result of the different structure of the Purkinje cell, coupling of excitation of the cell membrane with Ca2+ release in the core of these (large) cells differs substantially from that of myocytes. Immunostaining experiments in rabbit Purkinje cells show that RyRs are subsarcolemmal as well as within the cell consistent with earlier reports (106, 256, 505, 513). In fact, canine Purkinje cells contain both RyR3 and RyR2 isoforms with the RyR3 protein being located in a subsarcolemmal region. Here the action potential of the Purkinje cell precedes rapid Ca2+ entry into the subsarcolemmal space. The latter induces Ca2+ release which in some species propagates into the core of the Purkinje cells (64). In rabbit Purkinje cells, experiments with ryanodine suggest that Ca2+ changes in the central core of cells are best explained by simple buffered Ca2+ diffusion and not Ca2+ propagation (106). However, in rabbit Purkinje cells, evoked Ca2+ transients and sparks are only seen to originate at peripheral cellular components, suggesting that RyRs in the cell center of this type of cell are "silent" (106). This is consistent with voltage-clamp studies of single rabbit Purkinje cells which show a single-component Ca2+ transient (497). However, in canine Purkinje cells, electrically evoked Ca2+ transients are multiphasic (61, 64). An action potential evokes a sudden increase in Ca2+ particularly along the periphery. In some Purkinje cells from normal hearts, if electrically evoked peripheral release is spatially and temporally inhomogeneous, a local Ca2+ wave is produced and can propagate as a traveling Ca2+ wave the length of the aggregate as well as towards the cell's core (64, 513). Finally, while fundamentals of ECC have been described above, it is important to remember that the time course of the action potential (AP) of the cell can have significant modulatory effects on ECC efficiency. Not only does AP duration affect the time course of the evoked Ca2+ transient (58, 463), but altering the rate of early repolarization can affect both the magnitude and time course of SR Ca2+ release (464).
In a ventricular myocyte, the distance between Ca2+ release sites on the terminal cisternae of the SR to the Ca2+ transport molecules at the surface of the t tubules is less than
300 nm (i.e., from 40 nm to DHPR to
300 nm to Na+/Ca2+ exchangers). It follows that the transport molecules face the largest variation of [Ca2+]i within the cell. This review discusses potential consequences of the SR-related [Ca2+]i changes on function of membrane Ca2+ transport and how this feedback may be involved in modulation of action potential waveform and the development of arrhythmias. We anticipate that the cross-talk between the surface membrane and the SR is strongest in the working myocyte, given their high density of t tubules. In addition, it has become clear that rapid mechanical perturbations of the contracting cell may cause rapid Ca2+ dissociation from troponin C (TnC). Consequently, Ca2+ released from the myofilaments may also trigger Ca2+ release from the SR by CICR. While normal CICR occurs during the action potential, Ca2+ dissociation from the myofilaments may take place when the cell is repolarized. In that case, CICR could elicit a [Ca2+]i transient that in turn affects a different set of membrane channels.
| II. MOLECULAR BUILDING BLOCKS OF EXCITATION-CONTRACTION COUPLING |
|---|
|
|
|---|
1. Ca2+ entry through voltage-gated channels
There are several types of ion channels that are Ca2+ permeable. What has been termed as a background Ca2+ channel was originally defined in bilayer experiments (453, 454) (B-type Ca2+ channels). Under these conditions this channel spontaneously opens, has a relatively low conductance, is not blocked by nisoldipine, and is reasonably selective for Ba2+. Further investigations into resting Ca2+ influx into adult cardiac cells have shown the existence of spontaneously active Ca2+- and Ba2+-permeable but Ni2+-insensitive single channels in both cell-attached and inside-out patches (108). These latter channels are activated by phenothiazines such as chlorpromazine, trifluoperazine, and H2O2 but at very negative holding potentials (13, 314). A short report has stated that the voltage-independent B-type Ca2+ channel is regulatory in ceramide-induced rat myocyte apoptosis (201). While whole cell clamp data do not reveal such macroscopic inward currents in myocytes, some have suggested that this Na+-independent Ca2+ channel contributes importantly to tonic Ca2+ entry in the quiescent rat trabecula (307). The molecular nature of these background Ca2+ channels is unknown at this time.
The L-type (L for long lasting, ICaL) and T-type (T for transient, ICaT) Ca2+ currents were initially described in neuronal tissues. Bean et al. (31) first described multiple cardiac Ca2+ channels in canine atrial cells. At that time two types of Ca2+ currents carried by Ba2+ were recognized. Subsequently, ICaL and ICaT have been recorded in cardiac tissues of most species under various conditions. However, within the same species, the density of ICaL and ICaT varies depending on the location of the myocyte within the heart. Hagiwara et al. (189) first described the large density of both the L- and T-type channels in rabbit sinoatrial node (SAN) cells. Zhou and Lipsius (639) described large T-type currents in latent atrial pacemaker cells. Studies of cells dispersed from canine ventricles revealed a large peak T/L current density ratio in Purkinje cells dispersed both from free-running fiber bundles and the subendocardium of the left ventricle (LV) (212, 213, 548). In contrast, myocytes dispersed from mid and epicardial layers have a smaller T/L current ratio (548). Notably, T currents have not been observed in human atrial (366, 556), human ventricular (57, 366), or human Purkinje cells (P. Boyden, unpublished data).
Cardiac L- and T-type Ca2+ channels differ in the following biophysical properties. 1) Voltage range of activation: the T-channel activation occurs at more negative voltages than the L channel, e.g., in 5 mM [Ca2+]o the threshold for activation is 50 and 30 mV for T and L, respectively (548). 2) Voltage range of inactivation: in 5 mM [Ca2+]o, the T channel can be inactivated by membrane depolarization positive to 70 mV. The L channel remains fully available for activation at potentials more negative than 40 mV. 3) Mechanism of inactivation: T channel inactivates solely by membrane depolarization. For the L channel, both membrane depolarization and Ca2+ participate in the inactivation process.
Voltage-dependent inactivation of the L-type Ca2+ current is clearly evident as channels incorporated into lipid bilayers inactivate even when Ca2+ is buffered (453) and as noted from the dependence of the time course of Ba2+ current decay on voltage (14, 187). In fact, inactivation of L-type Ca2+ current can occur at voltage steps where "apparent" activation is absent. The molecular determinants of voltage-dependent inactivation of Ca2+ channels are less well understood than those of K+ or Na+ channels. In studies using Ba2+ as a charge carrier, several critical locations throughout the channel protein have been implicated in the fast (tens to hundreds of milliseconds) voltage-dependent inactivation process. They are the I-II linker, the proximal COOH terminus, the EF hand area in IC, and all four S6 regions (37, 40, 41, 59, 202, 203, 504, 624, 628). One model proposed suggests that a domain of the I-II linker docks to one or all of the S6 segments at the cytoplasmic end (85, 512). Importantly, this mechanism is not involved in the channel's "recovery from inactivation," only the channel's response to depolarization. Critical of course to these mechanisms is that Ba2+ permeating through these proteins show only voltage-dependent inactivation and no ion-dependent inactivation. However, recent data suggest that inactivation of the L-type Ca2+ channel when Ba2+ is the charge carrier may not be all due to a voltage-dependent process (157, 357).
The molecular basis of the cardiac L-type Ca2+ channel structure is due to the combination of the
1C-subunit [Cav1.2; see Ertel et al. (146) for nomenclature] (four 6-transmembrane segments joined by intracellular linkers with cytoplasmic NH2 and COOH termini) with
2-,
2/
-, and
-subunits. Alternative splicings of the
-subunit have been reported (for review, see Ref. 324) and two missense mutations in one exon appear to lead to abnormal Ca2+ current function in cells of patients with Timothy's syndrome (see sect. IVA3). Perhaps in some acquired diseases, alternatively spliced proteins constitute the remodeled Ca2+ channels in arrhythmogenic substrates. The
-subunit (33 kDa) is also expressed in skeletal muscle and in expression systems can have a modest effect on Ca2+ channel currents (112). Other studies have shown it can modulate Cav3.1, T-type Ca2+ channels (196). Its role in modulation of cardiac Ca2+ channels is minimal.
The Cav1.2 NH2 terminus can act as an inhibitory particle (490) as well as a site for modulation by Ca2+-binding proteins such as CaBP1 (635, 636), Ca2+/calmodulin protein kinase II (CaMKII) (227), calmodulin (CaM) (227, 636), and Cav
subunits (260). Some have suggested that a reduction in this inhibition can be caused by protein kinase C (PKC), which increases Cav1.2 Ca2+ currents (491); alternatively, phosphorylation of the NH2 terminus by PKC has been proposed to decrease the L-type Ca2+ current (613).
Other major sites of modulation of the
1C-subunit function are within the COOH terminus since it is the target of several kinases that regulate CaV1.2 L-type Ca2+ currents. Both PKA and CaMKII increase L-type Ca2+ current and change channel modal gating (139, 439, 621), and both effects are thought to be due to phosphorylation of the
1C COOH terminus (227, 613). Additionally, Src kinase phosphorylation of the neuronal
1C-isoform at a COOH-terminal residue leads to potentiation of the L-type Ca2+ current (36). However, the mechanisms by which specific kinases modulate L-type Ca2+ currents differ. For example, the major target for PKA in
1C has been identified as Ser1928 (122, 370); however, recent data suggest that phosphorylation of this site may not be required for adrenergic stimulation of L-type Ca2+ currents (166). Although CaMKII activation leads to the same shift in modal gating as that caused by PKA stimulation (139), and CaMKII also phosphorylates the COOH terminus, the specific targets are unknown. One report suggests that Ser1517 may be the target (147), but definitive biochemical evidence is lacking. PKC also phosphorylates Ser1928 (613), although the effects of this phosphorylation on L-type Ca2+ currents are unknown.
The
1C COOH terminus also contains a binding pocket for CaM (278), which mediates Ca2+-dependent inactivation and Ca2+-dependent facilitation of L-type Ca2+ channels (417, 643). The interaction between CaM and
1C is constitutive (145, 278). T-type Ca2+ currents do not show Ca2+-dependent inactivation (136, 213, 508); the
1G- and
1H-subunits lack the determinants for CaM binding in their respective COOH termini.
The voltage sensor for activation is the highly charged S4 segment. Ca2+ binding sites formed by glutamates in the pore loop of each repeat are critical for selectivity of the channel (144). Sections of the
1-subunit pore-forming segments, intracellular loops, and COOH terminus all contribute to Ca2+ channel inactivation. Mutating single amino acids in IIIS6 and IVS6 domains have a significant effect on current decay, suggesting that an area in the inner channel mouth is a key player in channel inactivation. Further point mutations in the intracellular I-II loop and the IVS5-IVS6 linker both affect Ca2+ channel inactivation. Notably, these sections of the protein are also critical sites of
-subunit and/or G protein interactions.
Currently, four potential
-subunits (Cav
1-
4) have been recognized, but in cardiac cells the
2-subunit predominates, providing a rate-limiting step in the expression of Ca2+ channel proteins (102). CaV
subunits are entirely cytoplasmic, and each subunit includes a variable NH2 terminus, a conserved core that includes an interacting Src homology domain, a guanylate kinase (GK)-like domain (90, 361, 402, 526), and a divergent COOH terminus. Both the NH2 terminus and SH3 domain contribute to isoform-specific regulation of channel inactivation (361). Interestingly, the GK domain contains the binding pocket for the
1 interaction domain (AID) on the
1-subunit. The role of the CaV
COOH terminus is still largely unknown, but
2 is a target for several kinases known to modulate L-type Ca2+ currents (e.g., the
2a COOH terminus is phosphorylated by PKA on Ser478 and Ser479). This phosphorylation appears to contribute to cAMP-dependent regulation of the channel (72).
The
1C-subunit (Cav1.2) when expressed alone is sufficient for L-type channel activity, but when expressed with a cytosolic
-subunit (52), peak currents increase fourfold, apparently by accelerating the opening of the pore and reducing the rate of channel closure (295, 371, 389, 391, 415). Furthermore, there is a shift in the activation curve, a slowing of activation, and an enhancement of the inactivation process (415).
2a-Subunits slow inactivation (243) due to palmitoylation of the NH2-terminal residues, and subsequent tethering to the membrane (509). A region of I-II intracellular linker the AID of the
-subunit forms the primary binding site for the accessory
-subunits (429). It is thought that this AID region forms an
-helix that becomes buried within a conserved domain common to all
-subunits (90, 402, 555). Interestingly, functional studies have revealed that while the AID region is not necessary for
-subunit modulation of Ca2+ currents, the tethering of
subunits to the AID region optimizes subunit orientation which in turn increases local
-subunit concentration (346, 526). Finally, cardiac L-type Ca2+ current facilitation also occurs when the
2a-subunit is coexpressed with the
1C-subunit (113).
The two-component
2/
-subunit (170 kDa) remains linked in vitro, with
2-subunit being an extracellular highly glycosylated protein;
is the short membrane-spanning protein with a fully glycosylated extracellular portion. Several members of this family exist with
2/
and
2/
2 being expressed in heart (170, 348). This subunit complex affects both ionic and gating currents of the expressed Ca2+ channels by increasing the number of functional channels at the cell surface (15, 25, 86, 281, 495). In one series of experiments, coexpression of
2/
with
1C
3-subunits prevented voltage-dependent facilitation (424). In these latter studies, this voltage-dependent facilitation was due to an increase in the number of channels that were able to produce gating current, as well as the number of channels that opened in response to voltage (424). Small molecules like the Ras-related G protein Gem have been shown to bind to
-subunits (33). Such binding apparently interferes with the subunit's ability to traffic the
-subunit to the membrane. Interestingly, gabapentin, a compound that has been shown to bind specifically to the
2/
-subunit (282), appears to have no consistent effect on expressed L-type Ca2+ currents (348).
Evidence suggests that the cardiac L-type Ca2+ channel protein in rabbit myocytes exists in two forms. One form is full length and comprises
20% of all
1C-subunits in rabbit membranes (122, 171, 173), while the other form, truncated at its COOH terminus, comprises
80% of all
1-subunits. The truncated form of the channel cannot be directly phosphorylated by PKA (122, 200), but remains in situ near the remaining
-subunit protein (169). Functionally, it has been shown that removal of the COOH terminus from the full-length protein results in an increase in channel activity (280, 582). Several peptides designed to mimic residues of the distal COOH terminus of the Cav1.2 protein also inhibit expressed Ca2+ currents, illustrating that a specific domain of residues 20242171 of the subunit functions to inhibit channel conductance (170). It is unclear as to whether the truncated Ca2+ channel and its COOH terminus remain fully functional in the in situ myocyte. However, this mechanism of modulation of L-type Ca2+ current amplitude has the potential of being an important contributor to ECC. For example, activation of N-methyl-D-aspartate (NMDA) receptors and subsequent L-type Ca2+ channel-mediated Ca2+ influx induces such COOH-terminal truncation resulting in sustained changes in Ca2+ channel activity (200).
In addition to
1C (Cav1.2), mRNA and protein from
1D (Cav1.3) subunits have been measured in heart tissues (448, 530, 604). Cav1.3 Ca2+ channel proteins are sparse, but this type of Ca2+ protein may serve a specific functional role. Expression studies have shown that currents mediated by Cav1.3 proteins (plus
2a-subunits) activate more quickly and decay more slowly than those of Cav1.2 proteins (288). Furthermore, steady-state inactivation and activation voltage relations of Ba2+ currents through Cav1.3 channels are shifted in the hyperpolarizing direction. These specific kinetic differences between Cav1.2 and Cav1.3 currents account in part for the decreased sensitivity of expressed Cav1.3 currents to dihydropyridine block (288). Finally, mice lacking
1D-subunit proteins are deaf and exhibit sinoatrial dysfunction and bradycardia, suggesting a role for
1D-proteins in SAN pacemaker activity (347, 425, 633). Interestingly, these mutant mice also show altered atrial Ca2+ currents and have inducible atrial fibrillation but no change in effective refractory period (ERP) (634). While Purkinje cells have not been studied in these mice, canine Purkinje cells express this protein, and two types of L-type Ca2+ currents have been described (548) suggesting that pacemaking in Purkinje cells may also involve Ca2+ currents through Cav1.3 channels.
The molecular basis of neuronal and cardiac T-type Ca2+ channels has been defined (111, 416). In both cases, the low-voltage T-type Ca2+ channel protein (
1H,
1G) (Cav3.3 and Cav3.2) has high sequence identity with the
1C-subunit particularly in the membrane-spanning regions (416). Charged residues of the S4 regions are conserved between
1C and
1H,
1G while a ring of glutamates important in
1C channel selectivity has been partially replaced by aspartates. T-type Ca2+ currents inactivate with voltage but not by Ca2+ (136, 508). Some have suggested that a "ball-and-chain" type mechanism involving the amino side of the COOH terminus contributes to T-type channel inactivation (74, 508). Perhaps more importantly in terms of possible targets for pharmacological modulation, intracellular loop motifs involved in
-subunit binding (306, 429) or Ca2+ binding (124) of the L-type
1C protein are missing in both the
1G and
1H proteins. In canine Purkinje cells, the large T currents most likely are due to Cav3.2 based on their kurtoxin sensitivity (448).
2. Na+/Ca2+ exchange, Ca2+ entry, and Ca2+ efflux
The cardiac Na+/Ca2+ exchanger protein transports Ca2+ across the sarcolemma in exchange for Na+ and is important in maintaining Ca2+ homeostasis in the myocyte. Na+/Ca2+ exchanger activity has been shown to affect various components of normal ECC [i.e., Ca2+spark frequency, SR Ca2+ release, and SR load (47, 176, 331)]. Normally, Na+/Ca2+ exchange works in the so-called forward mode, i.e., extruding Ca2+ in exchange for extracellular Na+. Reverse-mode operation of Na+/Ca2+ exchanger could provide additional Ca2+ influx into the cell. In the forward mode, Ca2+ are being transported out against their electrochemical gradient, and therefore, this mode of activity requires an expenditure of energy. It is generally accepted that the Na+ transcellular distribution indirectly provides the energy. Stoichiometric determinations have shown that three Na+ are transported for one Ca2+. Thus the exchanger is electrogenic. A recent study suggested that the stoichiometry may be closer to 4:1 Na+/Ca2+ (163, 261), but these data have been challenged (211). Under normal conditions, the reversal potential of the Na+/Ca2+ exchanger is 30 mV (279). Accordingly, negative to this potential Na+ flux is inward and Ca2+ flux is outward generating an inward current. Positive to 30 mV, the Na+/Ca2+ exchanger works in reverse mode, and outward current is generated. For the NCX1 transporter protein, it has been estimated that the turnover rate can be up to 5,000/s (209, 393) with a KD for [Ca2+]i of
6 µM (354). Recent data derived from the steady-state voltage and Ca2+ dependence of the Na+/Ca2+ exchanger protein have suggested that within <32 ms of an action potential upstroke, peak Ca2+ in a submembrane space is >3.2 µM (578). Thus Na+/Ca2+ exchanger current influences both the atrial and ventricular action potential (248). Furthermore, a component of observed transmural electrical heterogeneity of the left ventricle has been ascribed to basal differences in INa/Ca currents across the wall (647).
The Na+/Ca2+ exchanger protein is now considered to consist of nine transmembrane segments with a large (
550 amino acids) intracellular loop (loop f) between segments 5 and 6 (392). The Na+/Ca2+ exchanger gene NCX1 undergoes alternative splicing (NCX1.1, NCX1.3) in the COOH terminus of its large intracellular loop. Splice variants function differently with respect to regulating properties, and expression of NCX1.3 was found to protect against severe Ca2+ overload conditions (230). Distinct regions of the protein have been shown to be involved in the Na+/Ca2+ translocation process (135), while other regions, particularly loop f, are involved in the intrinsic regulation of the Na+/Ca2+ exchanger by Na+ and Ca2+ (355). Ca2+-dependent regulation of exchanger activity is via a high-affinity binding site (0.0220.4 µM) that is distinct from the Ca2+ transport site (354), is
130 amino acids in length, and is located in the center of loop f (316). Ca2+-dependent regulation of Na+/Ca2+ exchanger activity is apparently allosteric in ferret cells such that when [Ca2+]i levels are reduced (approximately <150 nM) Na+/Ca2+ current deactivates (577). A corollary is that when [Ca2+]i is elevated, steady-state activation of Na+/Ca2+ exchanger current increases, by as much as 67% for a doubling of [Ca2+]i. Such activation in normal cells promotes Ca2+ efflux with concomitant production of inward currents. If Ca2+ transients occur as traveling Ca2+ waves between cells, activated Na+/Ca2+ exchanger current would contribute to the occurrence of Ca2+-activated membrane currents.
Binding of the regulator Ca2+ decreases Na+-dependent inactivation of the Na+/Ca2+ exchanger (208). Intrinsic regulation of the Na+/Ca2+ exchanger by Na+ originally observed by Hilgemann (206) was termed Na+-dependent inactivation. This process is enhanced at low intracellular pH and diminished by micromolar Ca2+ (207). Mutagenesis studies suggest that the exchanger inhibitory peptide (XIP) binding site is located on loop f of the protein and is involved in the Na+-dependent inactivation of the exchanger (355). However, recent work with split exchanger proteins suggests that endogenous XIP region is not located between amino acids 265 and 672, since the activity of split exchanger with these loop residues deleted is still blocked (405). Other regulators of exchanger function include free radicals, pH, lipid products, as well as several kinases.
3. Stretch-sensitive Ca2+ flux
Stretch-activated ion channels have been described in both atrial and ventricular cells of several species (34, 226, 626). The channel is permeable to monovalent cations and Ca2+ (275) and thus can provide a source of Ca2+ influx. In single cells and isolated tissues from normal hearts, stretch has been observed to lead to a gradual (10 s) increase in [Ca2+]i (167, 533) as well as increases of inositol trisphosphate (IP3) and inositol tetrakisphosphate (IP4), both of which may modulate [Ca2+]i levels (119) and subsequent force development. In adult guinea pig cells, large stretch-induced [Ca2+]i changes are blocked by streptomycin (34, 168), a blocker of mechanosensitive transduction currents in hair cells (399), are not sensitive to ryanodine or tetrodotoxin (TTX), but sensitive to extracellular Ca2+. Interestingly, streptomycin also blocks stretch-induced atrial tachyarrhythmias in the isolated heart (19a), presumably by inhibiting mechanosensitive cation channels in atrial myocytes (168, 275, 276). In rat cells, stretch produces a slow increase (minutes) in the electrically evoked Ca2+ transient (222). Stretch of either rat myocytes or trabeculae increases both the frequency of SR Ca2+ release (seen as Ca2+ sparks) as well as the level of Akt and endothelial nitric oxide synthase (eNOS) phosphorylation. Thus it has been proposed that in response to stretch, myocytes generate nitric oxide (NO), which acts locally to modify ECC efficiency (419). Interestingly, sensitivity of a myocyte to stretch increases with age and degree of cellular hypertrophy (258).
Two Ca2+ can be transported by the cardiac SR Ca2+ pump for each ATP molecule consumed (524), although other stoichiometries have been reported. ATP binds to high-affinity binding sites on the cytoplasmic side of the pump. The terminal phosphate of ATP is transferred to aspartate-351 on the pump protein, and the bound Ca2+ are "occluded." ATP hydrolysis of the protein alters the structure such that Ca2+ cannot return to the cytoplasmic side. Phosphorylation also reduces the Ca2+ affinity of the pump such that Ca2+ can be released into the lumen of the SR.
The cardiac Ca2+ pump protein is the same as that from slow-twitch muscle (66, 67, 344) and has 10 membrane-spanning regions where each region, M1-M5, has additional
-helical "stalk" regions on the cytoplasmic side. Most of the 96-kDa protein is on the cytoplasmic side of the SR membrane including a
-strand, phosphorylation (aspartate-351) and nucleotide binding sites, stalk domains, and a hinge region. The crucial high-affinity Ca2+ binding sites were initially proposed to reside in the highly anionic stalk region (67); however, more recent data suggest that they are not in the stalk, but within the transmembrane regions M4-M6 and M8 (99, 100). It is likely that in the membrane these transmembrane domains may be arranged in a cylinder to form an ion channel through the SR bilayer (344).
The rate of the cardiac SR Ca2+ pump is highly regulated by phosphorylation of the protein phospholamban (522). In the dephosphorylated state, phospholamban interacts with the SR Ca2+ pump near the phosphorylation site of the pump (246), acting as an inhibitor of the Ca2+ pump activity. Phosphorylation removes the inhibitory effect and increases the pumping rate (205). Phospholamban is a homopentamer; the monomer has 52 amino acids and exhibits one hydrophobic and one hydrophilic domain. A proposed structural model states that the pentamer could have a hydrophilic pore through the SR membrane with phosphorylation sites on the cytoplasmic surface (494). Kovacs et al. (290) have obtained evidence that dephosphorylation of phospholamban can form Ca2+-sensitive channels in lipid bilayers. However, it is not clear whether or how the ionophoretic property might be related to the function of phospholamban in cardiac SR.
Phospholamban is phosphorylated by cAMP-dependent protein kinases (523). Studies from the intact perfused hearts show that
-adrenergic stimulation via PKA reduces the Km for Ca2+ and thus accelerates relaxation of the muscle (362). Ca2+-calmodulin dependent protein kinases and protein kinase C (PKC: Ca2+/phospholipid dependent) (244) also phosphorylate phospholamban at threonine-17 (579). The PKC site on phospholamban is Ser-10, but there is no evidence that this site is ever phosphorylated physiologically. Whether Thr-17 phosphorylation increases Vmax or Ca2+ affinity is controversial. This stimulation can result in an increase in SR content. The cardiac Ca2+ pump has two ATP binding sites: a high-affinity site (Kd
1 µM) that is the substrate site and a second lower affinity site (Kd
200 µM) that serves as a regulatory role (127, 138). The substrate for the Ca2+ pump is probably MgATP, but other nucleotides can be used (525). Therefore, the ATP level would have to be low to prevent ATP binding to the substrate site. However, decrease of the ATP level during ischemia slows SR Ca2+ pumping and relaxation.
2. Ryanodine-sensitive SR-Ca2+ release channels (RyR)
Two kinds of Ca2+ release channels found in the SR membrane, a Ca2+-activated channel and an IP3-activated channel, are proteins that form a distinct, highly conserved gene family. It is thought that the major mechanism regulating Ca2+ release in cardiac cells is CICR. CICR requires that Ca2+ provided by the activated L-type Ca2+ channel bind to the SR-Ca2+ release channel and cause opening of a high-conductance channel allowing rapid Ca2+ efflux from the SR. Studies of the SR-Ca2+ release channel have been greatly accelerated by the recognition that ryanodine, a plant alkaloid, is a selective and specific ligand for this channel. The RyR functionally constitutes the Ca2+ release channel of the SR and structurally represents the "foot" structure linking the t tubules to the SR. The recognition of selective ryanodine binding has allowed purification of several isoforms of RyR (RyR1, RyR2, RyR3) from skeletal (236, 239, 298) and cardiac (238, 297) muscle. Most of what is known about RyR comes from electrophysiological experiments on the channels after they have been incorporated into lipid bilayers (298, 456, 457, 502). Such experiments have suggested a biphasic response of the open probability of the channel (Po) to activating [Ca2+]. RyR2 Po increases up to micromolar concentrations of [Ca2+]i and then decreases at higher [Ca2+] (606, 609) (Fig. 4, A and B). Luminal [Ca2+] versus Po of RyR activity slightly differs between control wild-type RyR and mutated RyR (251) (Fig. 4C). Furthermore, the probability that a single RyR will be activated is determined by the amplitude and duration of Ca2+ trigger signals (623). The channel has a high Ca2+ conductance but can also conduct other divalent cations such as Ba2+ and Mg2+ (42, 97, 455) as well as monovalent ions in the absence of Ca2+ (502). Compared with the sarcolemmal Ca2+ channel (Cav1.2) under similar conditions, the SR Ca2+ release channel has lower selectivity for Ca2+ and 10-fold higher conductance (42). The ability of Ca2+ to cause release depends on [Ca2+]i, the rate of rise of [Ca2+]i at its receptor (151), as well as the presence of various nucleotides and Mg2+. RyR channels close rapidly either by deactivation (192) or decrease in trigger Ca2+. An increase of SR luminal [Ca2+] causes a marked increase in the Po of the Ca2+ release channel as well as the cell's resting Ca2+ spark frequency (27, 339, 500). Human atrial RyR share similar biochemical properties compared with ovine or canine ventricular counterparts (107). Refractoriness of SR release may be due in part to SR Ca2+ refilling mediated by the SR Ca2+ pump (521). Ryanodine, at low concentrations (<30 µM), opens the cardiac SR Ca2+ release channel in either vesicles or bilayers to a stable subconducting state and the channel no longer responds to Ca2+, ATP, Mg2+, or ruthenium red (363, 459). This probably is due to the occupation of the high-affinity ryanodine binding sites (Kd
10 nM). Very high concentrations of ryanodine (>100 µM) appear to lock the Ca2+ release channel in a closed state.
|
320450 kDa (238, 239, 297). The three-dimensional architecture of RyRs, reconstructed using image processing, matches that of the junctional "feet" observed by electron microscopy in muscle (54, 568). The gene product of cardiac RyR is smaller than, but homologous to, that of skeletal RyR (564,711 Da) (404, 529). The COOH termini of the isoforms are well conserved and contain highly hydrophobic segments probably forming 4 of the
10 transmembrane domains (M1-M4), with 2 additional transmembrane sequences near the center of the molecule. Recently, it has been shown (89) that substitution of alanine-3885 for glutamine near the putative transmembrane sequence of the M2 region of RyR3 reduced Ca2+ sensitivity of the channel 10,000-fold. Thus it has been proposed that glutamates of each RyR monomer cooperatively form the Ca2+ sensor of the RyR binding protein. Negatively charged residues within a transmembrane sequence are involved in binding and translocation of cations across the SR membrane (99, 611). This arrangement is attractive because it might confer Ca2+ sensitivity to RyR both at the cytoplasmic as well as the luminal side of the SR membrane. Novel high-resolution imaging electron microscopic techniques have allowed exciting progress in the structural understanding of SR Ca channels IP3R as well as RyR1, -2, and -3 (468, 481). Future progress will be facilitated by the development of crystallization procedures for these protein complexes (619). These studies have revealed that SR Ca2+ channels are strikingly similar tetrameric structures. We will review here the structure of SR Ca2+ release channels based on data from both cardiac RyR2 (629) and skeletal RyR1 (468).
Three-dimensional reconstruction of RyR1 has revealed a transmembrane domain and a large cytoplasmic assembly (Fig. 5A). The transmembrane domain is shaped as a square prism that is linked by columns in a narrower region to the cytoplasmic assembly (468). The cytoplasmic assembly itself forms a square that is rotated 45 degrees with respect to the prism. The center of the assembly gives access to a trough that connects to the Ca2+ channel in the depth of the transmembrane domain. The corners of the cytoplasmic assembly form the so-called "clamp." The sides form the "handle." A series of interconnected tubular structures form a rhomboid structure on the t-tubular surface of the clamp linking four domains (337).
|
-helices per monomer and closely resembles a closed K+ channel atomic structure (253, 337, 468) and may serve as the single Ca2+ channel formed by the tetramer. Four columns arise from the external peripheral branches of the transmembrane prism. Each column consists of two connections to the handle; in addition, two adjacent monomers are structurally linked. This creates a connection between each rhomboid structure with a column of the prism via a direct pathway as well as via an external arm of the handle. If the structures in this link exhibit elastic properties, one would expect a torsional force on the prism that should depend on the integrity of the rhomboid structure on the t-tubular surface of the clamp. The twist of the transmembrane prism (as in Fig. 5), observed in the closed state of the channel, is consistent with this notion. Releasing the torque on the molecule, by dissociation of the internal connections in the rhomboid structure, would be accompanied by untwisting the transmembrane prism as has been observed during opening of the channel (480).
The peptide sequences involved in the transmembrane domains are known to some extent, although the exact number of transmembrane sequences (
6) is still under study. Similarly, the location of the peptide sequences in the cytoplasmic domains is only partially known. The location of the peptide chains in the structure of the Ca2+ channel is still far from complete and even farther from conclusions regarding control mechanisms of the Po of the channel, and therefore, a detailed review of their location (cf. Refs. 332, 334, 350, 466; see also Refs. 35, 191, 333, 334, 465, 467, 629) is beyond the scope of this review. However, the proximity of mutations that affect the channel in skeletal muscle in malignant hyperthermia and central core disease and arrhythmogenic mutations in cardiac muscle suggests that the bridge in the rhomboid structure in the clamp is important to regulation of opening of the channel. The central domain of mutations that is involved in arrhythmias is again found in the bridge within the rhomboid structure of the clamp, suggesting that this structure in the clamp is important in the regulation of the opening probability of the channel.
Similar to what has been hypothesized for RyR1 channel proteins (609), it appears that RyR2 structure involves a critical interdomain interaction that plays a role in modulation of the channel's ability to release Ca2+. In this hypothesis, specific domains of the NH2 terminus interact to "zip" shut regions of the central core region. This zipped conformation has been linked to RyR2 channels with no Ca2+ "leak" (235). In disease and with RyR2 mutations, these regions can become unzipped to "leak" Ca2+ (see sect. IVA1). However, recent data also suggest that highly reactive free radicals destabilize these interdomain interactions and by themselves can cause partial dissociation of the FKBP12.6 binding protein (616).
Several studies have elucidated the sites for modulation of CICR (see reviews in Refs. 44, 88). Smaller modulatory proteins that have been found to copurify with RyR proteins are triadin (68, 183), sorcin, FKBP12.6 (249), PKA catalytic and regulatory subunits, MAKAP anchoring proteins, protein phosphatase (PP) 1 and PP2A (349), and calmodulin/CaMKII (44, 182). Recently, it has become known that RyR2 can be phosphorylated by at least two kinases, PKA and CaMKII, but each has a distinctive effect on RyR2 function. Ca2+ spark frequency of a normal myocyte increases with CaMKII stimulation due to a direct effect of phosphorylation of RyR2 (182). On the other hand, PKA-mediated effects to increase spark frequency appear to be related to an effect on SR load. The role of each of these kinases in abnormal Ca2+ spark frequencies accompanying disease awaits further study. It has been suggested that the FKBP12 protein is required for normal function of RyR2 playing a key role in the efficient so-called coupled gating between neighboring RyR2 channels (401). An immunosuppressant agent, FK506, binds to FKBP12 presumably inhibiting its modulation of RyR1, thereby increasing spontaneous [Ca2+]i transients by increasing the rate of release from the SR (358). FKBP12 null mice have RyR2 channels that exhibit abnormal gating in that there is a high occurrence of subconductance states (492). However, others have reported that removal of FKBP12.6 from RyR2 has no effect on RyR single-channel function (26). In rapamycin- or FK506-treated ventricular cells, presumably the loss of association of FKBP12 from RyR2 underlies the substantial increase in resting Ca2+ spark frequency (358).
A) POTASSIUM AND CHLORIDE CHANNELS IN THE SR MEMBRANE. The presence of large Ca2+ fluxes through the membrane of the SR requires the existence of other channels which allow large countercurrents to protect against electrical instability of the SR membrane. A large-conductance (150200 pS) K+ channel exists in both ventricular and atrial SR membranes and provides counter ion transport for Ca2+ release (1, 107, 159). Activation kinetics are slow with open times of 100 ms (455). There is no inactivation process. Typical K+ channel blockers (4-aminopyridine, iberiotoxin, amiodarone) are without effect (420). Ca2+ and Mg2+ do not alter the channel's activity (455), but its Po is reduced in low pH. The molecular identity of this protein is unknown at this time.
Additionally, a large-conductance (120 pS) Cl channel exists in SR membrane and can be also permeable to Ca2+ (516). This Cl channel's activity is altered with phosphorylation (125, 270, 458), and some have suggested that phospholamban modulates its conductance (125). The molecular identity of this protein remains unknown.
B) RYANODINE RECEPTORS AND CALCIUM OVERLOAD OF THE SR. Spontaneous SR Ca2+ release was first observed by Fabiato and Fabiato (153) in the form of spontaneous oscillatory contractions in skinned fibers. The spontaneous contractions were initiated by loading the SR using low [Ca2+]; the [Ca2+] used for the loading was by itself insufficient to induce Ca2+ release. The observation that skinned myocyte fragments started to contract in an oscillatory fashion led to the concept that a heavily Ca2+-loaded SR is characterized by spontaneous Ca2+ release. The importance of this phenomenon is that spontaneous contractions, caused by cytosolic [Ca2+]i oscillations (403, 588), are accompanied by spontaneous oscillations in current and membrane potential in both single myocytes as well as nondriven multicellular cardiac preparations (80, 264, 287). Agents that reduce Ca2+ load of the SR (e.g., ryanodine, caffeine, EGTA buffer) abolish spontaneous [Ca2+]i oscillations as well as the oscillatory potentials, current, and contractions (4, 353, 5